MRNA is not looking too good. What we can see is a weekly bearish engulfing candle after clear rejection from the upsloping resistance line. Rejection was nasty therefore we're seeing instant follow through. You can short it now with a final target at the support which is the entry for longs too. At the support, flip bullish and take a long position. The target...
Please like and share if you appreciate this market update. We are algorithmic traders and certified Elliotticians. We publish Elliott Wave and algo technical analysis on a daily basis for indices, stocks, cryptos, commodities, VIX, DXY, in weekly, daily and 4-hour timeframes. Our counts are not drawn subjectively but backed by solid algo trading evidence. We...
There is a daily wolfe wave setup that triggered on December 15. Today at the open, MRNA opened inside day and traded +4% within 30 mins of the trading day. The projected target is calculated by extending a linear line between pivot 1 and 4 and projecting the line; however, the linear lines do not converge. The projected target is approx 167 which is...
Moderna, Inc. ( NASDAQ:MRNA ) Sector: Health Technology (Biotechnology) Market Capitalization: $74.178B Current Price: $186.49 Breakout Price: $189.50 Buy Zone (Top/Bottom Range): $180.95-$147.05 Price Target: $204.50-$208.80 (1st), $258.80-$263.70 (2nd) Estimated Duration to Target: 34-37d, 91-96d Contract of Interest: $MRNA 9/16/22 190c, $MRNA 10/21/22...
You can see many supporting facts for my prediction on the chart... NASDAQ:MRNA
Not financial advice. The essence of investing & trading is the intelligent and patient preying on the greed, fear, impatience, addiction and ignorance of the majority. It's definitionally Darwinian.
Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). And recently we have seen it fall back to a very cheap price than it was back in 2 August 2021, In its current position we look to buy shares on MRNA as it is currently in a demand level.
MRNA Looking good for a OMICRON catalyst. Its a runner! PT's are subjective. This is not financial advice! Trade with caution & patience, but enjoy.
Moderna INC (MRNA) share price has had a reasonable decline, and now it feels we are bottoming a bit. The strategy short-term is, to BUY at $ 230-$245 range and taking profit at $ 285, which is the midd Donchian channel price. placed under $ 205.
The decline was sharp with a gap all due to disappointments. However, the decline was overdone, and way into the low bottom of the BB. Further, RSI quite low, and I feel we should fill the gap between $ 270-290 before we will see lower levels in the near-term. Buy $ 220-230 for profit level of $ 278.00. Stop-loss I think maybe 175.00.
Very good risk and reward. MRNA dropped more than 40% last week and extended from the 6 day moving average which is at 316. There is a wolfe wave setup on the 39 min time frame. The projected target is calculated by extending a linear line between pivot 1 and 4 and projecting the line. This is represented as the green perforated line, as shown in the chart. The...
On 7/15/2021 Jefferies Financial Group brokerage Boosted the Price Target from Positive to Hold from $170.00 to $250.00 On 5/7/2021 Morgan Stanley brokerage Lowered the Price Target to Equal Weight from $201.00 to $190.00 On 5/7/2021 The Goldman Sachs Group brokerage Boosted the Price Target to Buy from $206.00 to $228.00 My price target for MRNA is the Fib...
Hello! Friends, -This would be a great Buy Opportunity, IF NASDAQ:MRNA breaks up the Daily Resistance line at $164.00 (with a WHOLE DAILY Candle) !!
NASDAQ:MRNA technically setup for U-shape recovery and it has some positive news related to variants of the coronavirus in laboratory tests. The first resistance could be 169. Disclaimer: I"m NOT a financial advisor. All trades idea are shared for educational purposes only. All advice is based on technical and my own opinion.
Using measure move technique. NASDAQ:MRNA next resistance could be 235ish (166 + 66)
Chart has some good supports in current area (span B, K9, RSI=50) MACD had a cross under 0 (buying signal) The kumo cloud is getting thin so if k9 & k26 will cross it will be a good buying signal
Approaching 200 MA Gap filled Oversold Revenue will sky rocket with all of the vaccine orders MACD is improving Yes its pharma, yes it looks like a dumpster fire and we cant trust them BUT I can't help it. I see a bounce form $95-105 range to $135-155 range if not back to ATH after all the vaccine orders materialize in actual revenues. We might still dip more...